Other variables including age, sex, BMI, hypertension, and use of RAAS inhibitors, GLP-1 receptor agonists, and SGLT2 inhibitors showed no significant association after adjustment (Figure 2). This evidence concerns the gene SLC5A2 and hypertensive disorder.